Topalian Suzanne Louise bought VIR

October 27, 2026 · Form 4 insider transaction

Topalian Suzanne Louise bought 9,462 shares of Vir Biotechnology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
9,462
Price
$0.00
Total value
N/A
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateOctober 27, 2026
Filing dateOctober 28, 2026
Shares owned after25,462
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The shares subject to the stock option vest and become exercisable in full on the earlier of (i) October 27, 2027, or (ii) the date of the Issuer's next annual meeting of stockholders.

View the original Form 4 on SEC EDGAR